These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 20859663)

  • 1. Bioequivalence for topical products--an update.
    Narkar Y
    Pharm Res; 2010 Dec; 27(12):2590-601. PubMed ID: 20859663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioequivalence of topical generic products. Part 1: Where are we now?
    Miranda M; Sousa JJ; Veiga F; Cardoso C; Vitorino C
    Eur J Pharm Sci; 2018 Oct; 123():260-267. PubMed ID: 30053463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics-Based Approaches for Bioequivalence Evaluation of Topical Dermatological Drug Products.
    Raney SG; Franz TJ; Lehman PA; Lionberger R; Chen ML
    Clin Pharmacokinet; 2015 Nov; 54(11):1095-106. PubMed ID: 26063051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in methodologies for evaluating bioequivalence of topical formulations.
    Shah VP
    Am J Clin Dermatol; 2001; 2(5):275-80. PubMed ID: 11721645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence of topical generic products. Part 2. Paving the way to a tailored regulatory system.
    Miranda M; Sousa JJ; Veiga F; Cardoso C; Vitorino C
    Eur J Pharm Sci; 2018 Sep; 122():264-272. PubMed ID: 29981406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioequivalence of topical formulations in humans: evaluation by dermal microdialysis sampling and the dermatopharmacokinetic method.
    Benfeldt E; Hansen SH; Vølund A; Menné T; Shah VP
    J Invest Dermatol; 2007 Jan; 127(1):170-8. PubMed ID: 16874309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality and equivalence of topical products: A critical appraisal.
    Miranda M; Cardoso C; Vitorino C
    Eur J Pharm Sci; 2020 May; 148():105082. PubMed ID: 31626969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability and bioequivalence of topical glucocorticoids.
    Wiedersberg S; Leopold CS; Guy RH
    Eur J Pharm Biopharm; 2008 Mar; 68(3):453-66. PubMed ID: 17826047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of excised human skin to assess the bioequivalence of topical products.
    Franz TJ; Lehman PA; Raney SG
    Skin Pharmacol Physiol; 2009; 22(5):276-86. PubMed ID: 19707043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of topical bioequivalence using dermal microdialysis and tape stripping methods.
    Incecayir T; Agabeyoglu I; Derici U; Sindel S
    Pharm Res; 2011 Sep; 28(9):2165-75. PubMed ID: 21499834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical microdialysis in skin and soft tissues: an update.
    Schmidt S; Banks R; Kumar V; Rand KH; Derendorf H
    J Clin Pharmacol; 2008 Mar; 48(3):351-64. PubMed ID: 18285620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a dermatopharmacokinetic (DPK) method for bioequivalence assessment of topical metronidazole creams.
    Rath S; Ramanah A; Bon C; Kanfer I
    J Pharm Pharm Sci; 2020; 23():437-450. PubMed ID: 33156995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Update of the Brazilian Regulatory Bioequivalence Recommendations for Approval of Generic Topical Dermatological Drug Products.
    Soares KC; Santos GM; Gelfuso GM; Gratieri T
    AAPS J; 2015 Nov; 17(6):1517-8. PubMed ID: 26122498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioequivalence of topical corticosteroids: a regulatory perspective.
    Williams RL
    Int J Dermatol; 1992 Oct; 31 Suppl 1():2-5. PubMed ID: 1428462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of international regulatory bioequivalence recommendations for approval of generic topical dermatological drug products.
    Braddy AC; Davit BM; Stier EM; Conner DP
    AAPS J; 2015 Jan; 17(1):121-33. PubMed ID: 25344440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stratum Corneum Sampling to Assess Bioequivalence between Topical Acyclovir Products.
    Pensado A; Chiu WS; Cordery SF; Rantou E; Bunge AL; Delgado-Charro MB; Guy RH
    Pharm Res; 2019 Nov; 36(12):180. PubMed ID: 31728737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioequivalence studies of topical preparations: statistical considerations.
    Hauck WW
    Int J Dermatol; 1992 Oct; 31 Suppl 1():29-33. PubMed ID: 1428465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of dermal microdialysis for the evaluation of bioequivalence of a ketoprofen topical gel.
    Tettey-Amlalo RN; Kanfer I; Skinner MF; Benfeldt E; Verbeeck RK
    Eur J Pharm Sci; 2009 Feb; 36(2-3):219-25. PubMed ID: 18848881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of equivalence assessment of topical products based on the dermatopharmacokinetics approach.
    Boix-Montanes A
    Eur J Pharm Sci; 2011 Feb; 42(3):173-9. PubMed ID: 21094254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of dermatopharmacokinetic approach in the bioequivalence determination of topical tretinoin gel products.
    Pershing LK; Nelson JL; Corlett JL; Shrivastava SP; Hare DB; Shah VP
    J Am Acad Dermatol; 2003 May; 48(5):740-51. PubMed ID: 12734504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.